TITLE

Myocardial delayed enhancement in patients with pulmonary hypertension and right ventricular failure: evaluation by cardiac MRI

AUTHOR(S)
Jungqueira, F. P.; Macedo, R.; Coutinho Jr., A. C.; Loureiro, R.; De Pontes, P. V.; Domingues, R. C.; Gasparetto, E. L.
PUB. DATE
October 2009
SOURCE
British Journal of Radiology;Oct2009, Vol. 82 Issue 982, p821
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In this study, we evaluated patients with pulmonary arterial hypertension (PAH) and impaired right ventricular function. We used cardiac MRI for the detection of myocardial delayed enhancement (MDE) and its possible association with other clinical variables. 20 patients (6 males and 14 females, aged 44.5±11 years; 15 New York Heart Association class III, 5 class IV) with known PAH (13 idiopathic, 7 resulting from chronic pulmonary embolism) were evaluated for the detection of MDE. Short-axis cine images of the heart were made for ventricular function assessment using a steady-state free precession sequence. For MDE evaluation, a short-axis phase-sensitive inversion recovery sequence was performed 10 min after intravenous administration of 0.2 mmol kg-1 gadodiamide. Right ventricle (RV) systolic dysfunction, RV enlargement and RV hypertrophy were present in 20 patients (RV ejection fraction, 21.5±7.2%; RV diastolic diameter, 5.97±0.79 cm; RV wall thickness, 0.73±0.10 cm). 13 of the 20 patients (65%) were positive for MDE (10 anterior, 12 inferior). All 13 positive patients with MDE demonstrated small hyperintense areas at the insertion points of the RV free wall in the interventricular septum. We found no significant correlation between MDE and ejection fraction or other haemodynamic variables. In this study, MDE correlated positively only with the duration of disease. We found that septal MDE can be present in patients with PAH and impaired ventricular function. However, further studies are necessary to investigate this possible association and its prognostic implication.
ACCESSION #
44768159

 

Related Articles

  • Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Rajaram, Smitha; Swift, Andrew; Capener, David; Telfer, Adam; Davies, Christine; Hill, Catherine; Condliffe, Robin; Elliot, Charles; Hurdman, Judith; Kiely, David; Wild, Jim // European Radiology;Feb2012, Vol. 22 Issue 2, p310 

    Objective: To evaluate the diagnostic accuracy of contrast-enhanced MR angiography (CE-MRA) and the added benefit of unenhanced proton MR angiography compared with CT pulmonary angiography (CTPA) in patients with chronic thromboembolic disease (CTE). Methods: A 2 year retrospective study of 53...

  • Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Ley, Sebastian; Ley-Zaporozhan, Julia; Pitton, Michael; Schneider, Jens; Wirth, Gesine; Mayer, Eckhard; Düber, Christoph; Kreitner, Karl-Friedrich // European Radiology;Mar2012, Vol. 22 Issue 3, p607 

    Objectives: To determine the most comprehensive imaging technique for the assessment of pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Methods: 24 patients with CTEPH were examined by ECG-gated multi-detector CT angiography (MD-CTA), contrast-enhanced...

  • Lepirudin.  // Reactions Weekly;6/20/2009, Issue 1257, p26 

    The article describes the case of a 75-year-old man who acquired thrombosis while taking lepirudin for anticoagulation. He experienced a massive pulmonary embolism and underwent bilateral pulmonary endarteriectomy for persistent pulmonary hypertension. His magnetic resonance imaging (MRI)...

  • Noninvasive Functional Measurements of Right Ventricular Function. Johnson, Martin // Current Medical Literature: Pulmonary Hypertension;2011 Supplement, p6 

    In this article the author discusses some developments in the diagnosis of pulmonary arterial hypertension (PAH). The author mentions the significant role played by right ventricular function in the prognosis of idiopathic pulmonary hypertension (PH). He cites various noninvasive functional...

  • ARE WE SCREENING SURVIVORS OF PULMONARY EMBOLISM (PE) FOR CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH)? Wilczynska, M.; Taylor, K. // Thorax;Dec2011 Supplement, pA69 

    Background Incidence of CTEPH following idiopathic PE has been reported as 4%. The British Thoracic Society recommends that patients with massive or submassive PE should undergo echocardiography 6-12 weeks following the index event. Aim To investigate local practice in the follow-up of patients...

  • Quantitative estimation of right ventricular hypertrophy using ECG criteria in patients with pulmonary hypertension: A comparison with cardiac MRI. Blyth, Kevin G.; Kinsella, James; Hakacova, Nina; McLure, Lindsey E.; Siddiqui, Adeel M.; Wagner, Galen S.; Peacock, Andrew J. // Pulmonary Circulation;2011, Vol. 1 Issue 4, p470 

    In patients with pulmonary arterial hypertension (PAH), right ventricular mass (RVM) correlates linearly with pulmonary artery pressure, and decreases with successful treatment. Accurate measurement of RVM currently requires cardiovascular magnetic resonance (CMR) imaging. We therefore tested...

  • News & views. Hinchey, Kevin T. // Cortlandt Forum;10/25/97, Vol. 10 Issue 10, p34 

    Presents an abstract and comment on the study `Diagnosis of Pulmonary Embolism With Magnetic Resonance Angiography,' by J.F.M. Meany, J.G. Weg et al and published in a 1997 issue of the `New England Journal of Medicine.'

  • MRI diagnoses clots in lung.  // Executive Health's Good Health Report;Aug97, Vol. 33 Issue 11, p2 

    Focuses on the study on the use of the magnetic resonance imaging (MRI) technology in the diagnosis of pulmonary embolism. Use of a contrast dye allowing radiologists to take an X-ray picture of the lung vessels; Advantage over the standard pulmonary arteriography; Correlation between the...

  • Step Aside, CT.  // ASRT Scanner;Jun/Jul2012, Vol. 44 Issue 5, p10 

    The article reports on the claim by Doctor Diego Martin of the University of Arizona College of Medicine's Radiology Department that magnetic resonance (MR) imaging will replace computed tomography (CT) in diagnosing pulmonary embolism in the near future.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics